TrialBreast cancer research and treatment2025

Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer.

Karen Page et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.